Cargando…
New Synthetic Thrombin Inhibitors: Molecular Design and Experimental Verification
BACKGROUND: The development of new anticoagulants is an important goal for the improvement of thromboses treatments. OBJECTIVES: The design, synthesis and experimental testing of new safe and effective small molecule direct thrombin inhibitors for intravenous administration. METHODS: Computer-aided...
Autores principales: | Sinauridze, Elena I., Romanov, Alexey N., Gribkova, Irina V., Kondakova, Olga A., Surov, Stepan S., Gorbatenko, Aleksander S., Butylin, Andrey A., Monakov, Mikhail Yu., Bogolyubov, Alexey A., Kuznetsov, Yuryi V., Sulimov, Vladimir B., Ataullakhanov, Fazoyl I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095642/ https://www.ncbi.nlm.nih.gov/pubmed/21603576 http://dx.doi.org/10.1371/journal.pone.0019969 |
Ejemplares similares
-
The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency
por: Gribkova, Irina V., et al.
Publicado: (2016) -
Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation
por: Sinauridze, Elena I., et al.
Publicado: (2017) -
Application of Molecular Modeling to Development of New Factor Xa Inhibitors
por: Sulimov, Vladimir B., et al.
Publicado: (2015) -
Antiplatelet Agents Can Promote Two-Peaked Thrombin Generation in Platelet Rich Plasma: Mechanism and Possible Applications
por: Tarandovskiy, Ivan D., et al.
Publicado: (2013) -
Erythrocytes as bioreactors to decrease excess ammonium concentration in blood
por: Protasov, Eugeniy S., et al.
Publicado: (2019)